EPS for Jiangsu Hengrui Medicine (600276.SS)

EPS in 2023 (TTM): $0.14

According to Jiangsu Hengrui Medicine 's latest financial reports the company's current EPS (TTM) is $0.14. In 2022 the company made an earnings per share (EPS) of $0.14 a decrease over its 2021 EPS that were of $0.17.

EPS history for Jiangsu Hengrui Medicine from 2002 to 2023

Annual EPS

Year	EPS	Change
2023 (TTM)	$0.14	-5.18%
2022	$0.14	-17.1%
2021	$0.17	-24.44%
2020	$0.23	20.3%
2019	$0.19	25.58%
2018	$0.15	27.55%
2017	$0.12	21.64%
2016	$0.09816	13.57%
2015	$0.08643	39.86%
2014	$0.06180	21.33%
2013	$0.05093	17.7%
2012	$0.04328	25.56%
2011	$0.03447	26.22%
2010	$0.02731	10.3%
2009	$0.02476	57.92%
2008	$0.01568	11.06%
2007	$0.01411	85.81%
2006	$0.007596	87.94%
2005	$0.004042	33.97%
2004	$0.003017	29.78%
2003	$0.002325	19.78%
2002	$0.001941

What is the market capitalization of a company?

The market capitalization sometimes referred as Marketcap, is the value of a publicly listed company.
In most cases it can be easily calculated by multiplying the share price with the amount of outstanding shares.

DISCLAIMER

CompaniesMarketCap is not associated in any way with CoinMarketCap.com
Stock prices are delayed, the delay can range from a few minutes to several hours.
Company logos are from the CompaniesLogo.com logo database and belong to their respective copyright holders. Companies Marketcap displays them for editorial purposes only.

Contact

For inquiries or if you want to report a problem write to hello@8marketcap.com

Links

- Privacy policy

- Terms and conditions